Our Science

Moving discoveries

Ludwig's integrated technology development programs, led by Jonathan Skipper, are built to seamlessly move the most promising breakthroughs from the laboratory to clinical testing. We don't wait and hope for others to act on our work, we have dedicated teams to manage every step, from drug discovery to the clinic and beyond. At Ludwig, we test our work against the one measure that matters—human benefit.

Go to making discoveries

Technology licensing

The first step in Ludwig's drive to accelerate the life-changing possibilities of our science is careful management of intellectual property. The Ludwig Institute's in-house technology development team works closely with our scientists, spotting patent opportunities, building partnerships and maximizing the potential uses of our breakthroughs. Our expertise in patents, licensing, contracts, portfolio development, clinical trials and start-up biotech ensures that our discoveries will be pursued along multiple avenues both within the Ludwig community and with partners anywhere in the world.

For more on Ludwig's technology licensing team and their capabilities, click here.

 

Scientists
Intellectual property
Research tools

Monoclonal antibodies and hybridoma cell lines originated by Ludwig Institute scientists are available for licensing. Click here for a searchable PDF.

Several biological models also are available:
Immortomouse®
TNF alpha knock-out mice
PI3K Transgenic models

Related Success Stories